Related references
Note: Only part of the references are listed.The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1-and FAAH-independent mechanisms
Barbara Bosier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Effects of Monoamine Reuptake Inhibitors in Assays of Acute Pain-Stimulated and Pain-Depressed Behavior in Rats
Marisa B. Rosenberg et al.
JOURNAL OF PAIN (2013)
Expression and treatment of pain-related behavioral depression
S. Stevens Negus
LAB ANIMAL (2013)
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
Josee Guindon et al.
PHARMACOLOGICAL RESEARCH (2013)
Effects of the Delta Opioid Receptor Agonist SNC80 on Pain-Related Depression of Intracranial Self-Stimulation (ICSS) in Rats
S. Stevens Negus et al.
JOURNAL OF PAIN (2012)
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
John P. Huggins et al.
PAIN (2012)
Dissociable Effects of the Cannabinoid Receptor Agonists Δ9-Tetrahydrocannabinol and CP55940 on Pain-Stimulated Versus Pain-Depressed Behavior in Rats
Andrew J. Kwilasz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Effects of Alterations in Cannabinoid Signaling, Alone and in Combination with Morphine, on Pain-Elicited and Pain-Suppressed Behavior in Mice
Laurence L. Miller et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
L. J. Alvarez-Jaimes et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase
Jonathan Z. Long et al.
JOURNAL OF LIPID RESEARCH (2011)
Inactivation of Lipid Glyceryl Ester Metabolism in Human THP1 Monocytes/Macrophages by Activated Organophosphorus Insecticides Role of Carboxylesterases 1 and 2
Shuqi Xie et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Matthias Karst et al.
DRUGS (2010)
Antagonism of Δ9-THC induced behavioral effects by rimonabant: Time course studies in rats
Torbjoern U. C. Jaerbe et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats
S. Stevens Negus et al.
PSYCHOPHARMACOLOGY (2010)
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
Joel E. Schlosburg et al.
AAPS JOURNAL (2009)
URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats
Parisa Hasanein et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats
Gail Pereira Do Carmo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behavior
Gail Pereira Do Carmo et al.
PAIN (2009)
Inhibition of fatty acid amide hydrolase produces PPAR-α-mediated analgesia in a rat model of inflammatory pain
D. R. Sagar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action
C. J. Fowler
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Antinociceptive pharmacology of N-(4-chlorobenzyl)-N′-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor
Lei Tang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation
William A. Carlezon et al.
NATURE PROTOCOLS (2007)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
Preclinical assessment of candidate analgesic drugs: Recent advances and future challenges
S. S. Negus et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A FAAH-regulated class of N-acyl taurines that activates TRP ion channels
Alan Saghatelian et al.
BIOCHEMISTRY (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation
D Fegley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin
AG Hohmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development
J De Vry et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Functional disassociation of the central and peripheral fatty acid amide signaling systems
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Anandamide and vanilloid TRPV1 receptors
RA Ross
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Share Paper
